Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand

Novavax raised its annual revenue forecast after beating quarterly expectations on Thursday, as the vaccine maker's licensing-driven milestone payments helped offset waning demand.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。